Trial intelligence / Profile preview

Diabetes in the Very Elderly Trial

2005-001027-11Phase 4Terminated

Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of metformin and gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Primary endpoints: Adverse drug effect rates, Withdrawal from active treatment due to adverse effects and 1 more. Started May 2005; status: terminated.

02

Drugs

metformingliclazide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2005-001027-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001027-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call